Additional information
| Active substance | Apremilast |
|---|---|
| Water Retention | No significant effect |
| Hepatotoxicity | Minimal to no hepatotoxicity reported |
| Lab Test | Monitoring is not typically required for liver enzymes unless under specific medical advice |
| Strength | 30mg |
| Also known as | CC-10004 |
| Blood pressure | No significant effects on blood pressure |
| Trade name | Otezla |
| Storage conditions | Store at 20В°C to 25В°C (68В°F to 77В°F), excursions permitted between 15В°C to 30В°C (59В°F to 86В°F) |
| Chemical name | N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide |
| Formula | C22H24N2O7S |
| Substance class | Phosphodiesterase 4 (PDE4) inhibitor |
| Main action | Anti-inflammatory |
| Half-life | Approximately 6-9 hours |
| Dosage (medical) | 30 mg twice daily after initial titration |
| Dosage (sports) | Not applicable |
| Effects | Reduces inflammation by inhibiting PDE4, an enzyme involved in the process of inflammatory response |
| Side effects | Diarrhea, nausea, headache, upper respiratory tract infection, weight loss |
| Use in sports | Not typically used in sports, lacks performance-enhancing properties |
| Manufacturer | Glenmark Pharmaceuticals Ltd. |
| Packing | 10 tabs/blister |
Norvacs 5 mg Pfizer
Balkan Pharma Anapolon 50 mg 60 Tabletten
Chorionic Gonadotrophin Injection IP 5000 IU Puretrig
LACIPIL 4 mg Glaxosmithkline
Muscoflex 8 mg Bilim
Spiriva HandiHaler 18mg Boehringer Ingelheim
FACTIVE 320 mg Abdi Ibragim
FUCIDIN 500 mg Abdi Ibragim
Fostimon (Merional) 150 IU HMG IBSA
Prograf 1mg Astellas Pharma
Seretide Disckus (Advair) 250 mcg Glaxosmithkline 

Reviews
There are no reviews yet.